Migraines Headaches News
- FDA Approves Fast-Acting Nasal Spray for Migraines, Pfizer Says
March 10, 2023 — Clinical trials showed the nasal spray provided migraine relief within 15-30 minutes of use, with the relief lasting up to 48 hours in many patients.
- FDA Approves First of New Migraine Drugs
May 17, 2018 — The FDA has approved the first in a new class of migraine drugs, called CGRP inhibitors, that aim to head off fight painful migraine headaches before they start.